Charlotte's Web Holdings (CWBHF) Net Income towards Common Stockholders (2021 - 2026)

Charlotte's Web Holdings' (CWBHF) quarterly Net Income towards Common Stockholders came in at -$13.1 million in Q1 2026, down 111.08% year-on-year from $118.4 million in Q1 2025, and down 14.79% on a QoQ basis from -$11.4 million in Q4 2025.

Charlotte's Web Holdings (CWBHF) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends

Charlotte's Web Holdings (CWBHF) has 6 years of Net Income towards Common Stockholders data on file, last reported at -$13.1 million in Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders fell 111.08% year-over-year to -$13.1 million in Q1 2026; TTM through Mar 2026 was -$36.6 million, a 38.67% decrease from a year earlier, with the FY2025 full-year figure at -$29.7 million, changed 0.35% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at -$13.1 million, down from -$11.4 million in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for CWBHF reached as high as $2.8 million in Q2 2023 and fell as low as -$35.2 million in Q4 2022.
  • Historically, Net Income towards Common Stockholders has averaged -$9.2 million across 5 years, with a median of -$7.9 million in 2022.
  • Across the five-year window, Net Income towards Common Stockholders tumbled 876.58% in 2022 and soared 136.14% in 2023, its largest moves.
  • Year by year, Net Income towards Common Stockholders stood at -$35.2 million in 2022, then jumped by 75.63% to -$8.6 million in 2023, then soared by 60.77% to -$3.4 million in 2024, then plunged by 239.16% to -$11.4 million in 2025, then dropped by 14.79% to -$13.1 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were -$13.1 million in Q1 2026, -$11.4 million in Q4 2025, and -$5.8 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Haleon 89.28 Bn 87.42 Bn - -
2 Teva Pharmaceutical Industries 35.97 Bn 32.23 Bn 1.97 Bn 370.00 Mn
3 Zoetis 32.42 Bn 30.48 Bn 1.62 Bn 601.00 Mn
4 Takeda Pharmaceutical 27.48 Bn 23.42 Bn 4.39 Bn -2.35 Bn
5 United Therapeutics 22.89 Bn 20.73 Bn 648.10 Mn 274.90 Mn
6 RedHill Biopharma 22.11 Bn 22.11 Bn - -
7 Viatris 20.44 Bn 18.64 Bn 1.16 Bn 176.40 Mn
8 Neurocrine Biosciences 17.76 Bn 16.44 Bn 800.70 Mn 197.90 Mn
9 Elanco Animal Health 12.62 Bn 12.19 Bn 785.00 Mn 57.00 Mn
10 Charlotte's Web Holdings 41.51 Mn 36.32 Mn 5.20 Mn -13.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -13.11 Mn
Dec 31, 2025 -11.42 Mn
Sep 30, 2025 -5.82 Mn
Jun 30, 2025 -6.29 Mn
Mar 31, 2025 -6.21 Mn
Dec 31, 2024 -3.37 Mn
Sep 30, 2024 -5.79 Mn
Jun 30, 2024 -11.06 Mn
Mar 31, 2024 -9.63 Mn
Dec 31, 2023 -8.59 Mn
Sep 30, 2023 -15.14 Mn
Jun 30, 2023 2.84 Mn
Mar 31, 2023 -2.91 Mn
Dec 31, 2022 -35.23 Mn
Sep 30, 2022 -7.59 Mn
Jun 30, 2022 -7.87 Mn
Mar 31, 2022 -8.63 Mn
Dec 31, 2021 -118.25 Mn
Sep 30, 2021 -777,000.00
Jun 30, 2021 -5.92 Mn